⌘K

Login Start Free

Home/Filings/4/0001641172-25-003089

4//SEC Filing

SHAH BIMAL R. 4

Accession 0001641172-25-003089

CIK 0001815974other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 9:41 PM ET

Size

19.8 KB

Accession

0001641172-25-003089

Insider Transaction Report

Form 4

Period: 2025-04-04

Anebulo Pharmaceuticals, Inc.ANEB

Director

Transactions

Award
Stock Option (right to buy)
2025-04-04+25,000→ 25,000 total
Exercise: $1.02Exp: 2035-04-03→ Common Stock (25,000 underlying)
Award
Stock Option (right to buy)
2025-04-04+6,618→ 6,618 total
Exercise: $1.02Exp: 2035-04-03→ Common Stock (6,618 underlying)

Footnotes (1)

[F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.

Documents

2 files

Issuer

Anebulo Pharmaceuticals, Inc.

CIK 0001815974

Entity typeother

Related Parties

1

filerCIK 0001557394

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 9:41 PM ET
Size: 19.8 KB

View on SEC.gov